Clinical Trial Update: Evaluation of the Optimal MTX Dose as an Add-on Therapy to Adalimumab for RA Patients in Japan, South Korea and Taiwan [Phase 4]

View source ↗

Summary

A Phase 4 trial from Keio University evaluates the optimal methotrexate dose as add-on therapy to adalimumab in rheumatoid arthritis patients across Japan, Sout…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Keio University | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2025-03-06